Hikma Pharmaceuticals Statistics

Total Valuation

HKMPY has a market cap or net worth of 5.57 billion. The enterprise value is 6.75 billion.

Market Cap	5.57B
Enterprise Value	6.75B

Important Dates

The next estimated earnings date is Thursday, August 7, 2025.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	Mar 21, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.51%
Shares Change (QoQ)	-0.24%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	153.47M

Valuation Ratios

The trailing PE ratio is 15.53.

PE Ratio	15.53
Forward PE	n/a
PS Ratio	1.78
PB Ratio	2.40
P/TBV Ratio	4.83
P/FCF Ratio	13.97
P/OCF Ratio	9.88
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.97, with an EV/FCF ratio of 16.91.

EV / Earnings	18.79
EV / Sales	2.03
EV / EBITDA	7.97
EV / EBIT	10.44
EV / FCF	16.91

Financial Position

The company has a current ratio of 1.14, with a Debt / Equity ratio of 0.56.

Current Ratio	1.14
Quick Ratio	0.60
Debt / Equity	0.56
Debt / EBITDA	1.64
Debt / FCF	3.27
Interest Coverage	8.11

Financial Efficiency

Return on equity (ROE) is 15.98% and return on invested capital (ROIC) is 10.82%.

Return on Equity (ROE)	15.98%
Return on Assets (ROA)	7.74%
Return on Invested Capital (ROIC)	10.82%
Return on Capital Employed (ROCE)	19.27%
Revenue Per Employee	329,158
Profits Per Employee	37,789
Employee Count	9,500
Asset Turnover	0.64
Inventory Turnover	1.82

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.05% in the last 52 weeks. The beta is 0.69, so HKMPY's price volatility has been lower than the market average.

Beta (5Y)	0.69
52-Week Price Change	+9.05%
50-Day Moving Average	53.21
200-Day Moving Average	51.21
Relative Strength Index (RSI)	53.32
Average Volume (20 Days)	754

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKMPY had revenue of 3.13 billion and earned 359.00 million in profits. Earnings per share was 1.61.

Revenue	3.13B
Gross Profit	1.42B
Operating Income	608.00M
Pretax Income	455.00M
Net Income	359.00M
EBITDA	787.00M
EBIT	608.00M
Earnings Per Share (EPS)	1.61

Full Income Statement

Balance Sheet

The company has 213.00 million in cash and 1.31 billion in debt, giving a net cash position of -1.09 billion.

Cash & Cash Equivalents	213.00M
Total Debt	1.31B
Net Cash	-1.09B
Net Cash Per Share	n/a
Equity (Book Value)	2.32B
Book Value Per Share	10.48
Working Capital	285.00M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 564.00 million and capital expenditures -165.00 million, giving a free cash flow of 399.00 million.

Operating Cash Flow	564.00M
Capital Expenditures	-165.00M
Free Cash Flow	399.00M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 45.25%, with operating and profit margins of 19.44% and 11.48%.

Gross Margin	45.25%
Operating Margin	19.44%
Pretax Margin	14.55%
Profit Margin	11.48%
EBITDA Margin	25.17%
EBIT Margin	19.44%
FCF Margin	12.76%

Dividends & Yields

This stock pays an annual dividend of 1.56, which amounts to a dividend yield of 3.10%.

Dividend Per Share	1.56
Dividend Yield	3.10%
Dividend Growth (YoY)	11.43%
Years of Dividend Growth	8
Payout Ratio	48.75%
Buyback Yield	-0.51%
Shareholder Yield	2.59%
Earnings Yield	6.44%
FCF Yield	7.16%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKMPY has an Altman Z-Score of 2.87. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.87
Piotroski F-Score	n/a